Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

计划入组 200 人 · 首次发布于 2026 年 7 月 20 日

Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study

计划入组 72 人 · 首次发布于 2026 年 7 月 31 日

Evaluating a Water Quality Assurance Fund Intervention in Ghana and Kenya

计划入组 4,800 人 · 首次发布于 2024 年 8 月 26 日

RFUSIN2-AML1(Leukemia Research Fund)

Quadrivalent inactivated influenza vaccine (Fluart Innovative Vaccines)

177Lu/225Ac labeled alphavbeta3-integrin targeting peptidomimetics (Advanced Innovative Partners)

WORLDWIDE INNOVATIVE NETWORK

France

Innovative Molecules GmbH

Germany

Blueprint Medicines

United States

NHS Approves Oxbryta for Sickle Cell Disease Following Price Reduction Agreement

UK and Denmark Approve CSL's Hemgenix Gene Therapy for Haemophilia B with Novel Reimbursement Models

NHS Approves Fenfluramine for Children with Lennox-Gastaut Syndrome, Offering New Hope for Severe Epilepsy Treatment